CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (CHRU);UNIVERSITE DU LITTORAL COTE D'OPALE;UNIVERSITE DE LILLE 2 DROIT ET SANTE
发明人:
David Devos,Caroline Moreau,Charlotte Laloux,Jean-christophe Devedjian
申请号：
US15310364
公开号：
US20170151193A1
申请日:
2015.05.12
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention is directed to pharmaceutical solution comprising at least dopamine for use in treating Parkinson's disease, wherein said pharmaceutical solution is kept under anaerobic conditions from its firmation to its administration.
